Through using neutralizing antibody and siRNA approaches to suppress PDL1–PD1 axis, we have verified that ABs switch macrophages from a pro‐inflammatory state to an anti‐inflammatory state through PDL1–PD1 axis, providing therapeutic benefits in the treatment of ALI and inflammatory arthritis. The gene discussed is PDCD1; the disease is acute respiratory distress syndrome.